Safety and Efficacy of Zuretinol Acetate in Subjects With Inherited Retinal Disease
Clinical trial NCT04311112 · WITHDRAWN
Trial details
- NCT number
- NCT04311112
- Sponsor
- Retinagenix Holdings
- Status
- WITHDRAWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2023-02-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.